Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Pharmacia Limited
Ramsgate Road, Sandwich, Kent, CT13 9NJ
Telephone: +44 (0)1304 616 161
Fax: +44 (0)1304 656 221

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Summary of Product Characteristics last updated on the eMC: 03/09/2009
SPC Estracyt Capsules

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 03/09/2009 and displayed until Current
Reasons for adding or updating:
  • Correction of spelling/typing errors
Date of revision of text on the SPC:   13-Nov-2008
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
None provided
Updated on 24/11/2008 and displayed until 03/09/2009
Reasons for adding or updating:
  • Change to section 4.4 - Special warnings and precautions for Use
  • Change to section 4.8 - Undesirable Effects
  • Change to section 5.1 - Pharmacodynamic Properties
Date of revision of text on the SPC:   13-Nov-2008
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company


-          section 4.4 – co-administration with vaccines

-          section 4.8 - Reported reactions arranged according to MedDRA System Organ System

-          section 5.1 – addition of ATC code
Updated on 26/08/2008 and displayed until 24/11/2008
Reasons for adding or updating:
  • Change to section 3 - Pharmaceutical form
Date of revision of text on the SPC:   14-Aug-2008
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
Section3. Pharmaceutical Form – addition of ‘White, hard’, gelatine capsules.
Updated on 26/06/2008 and displayed until 26/08/2008
Reasons for adding or updating:
  • Change of inactive ingredient
Date of revision of text on the SPC:   01-Jun-2008
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
None provided
Updated on 07/08/2007 and displayed until 26/06/2008
Reasons for adding or updating:
  • Change to section 4.1 - Therapeutic indications
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   07/2007
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
 
Section 4.1 – Change in the name of polyoestradiol (Ban) to polyestradiol (INN)
 
Section 10 – Change in the date of revision
Updated on 18/07/2007 and displayed until 07/08/2007
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
Date of revision of text on the SPC:   07/2007
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Section 7.0 – Marketing Authorisation Holder
Updated on 03/06/2004 and displayed until 18/07/2007
Reasons for adding or updating:
  • Change to section 6. 3 - Shelf Life
  • Change to section 6. 4 - Special Precautions for Storage
  • Change to section 10 (date of (partial) revision of the text
  • Change to section 4.4 - Special Warnings and Precautions for Use
Updated on 23/04/2003 and displayed until 03/06/2004
Reasons for adding or updating:
  • Change to section 4.5 - Interactions with other Medicaments and other forms of Interaction
  • Change to section 4.8 - Undesirable Effects
  • Change to section 10 (date of (partial) revision of the text
Updated on 10/07/2002 and displayed until 23/04/2003
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 04/07/2002 and displayed until 10/07/2002
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
  • Change to section 8 - MA number
  • Change to section 9 - Date of Renewal of Authorisation
Updated on 04/03/2002 and displayed until 04/07/2002
Reasons for adding or updating:
  • Change to section 4.8 - Undesirable Effects
  • Change to section 10 (date of (partial) revision of the text
Updated on 20/08/2001 and displayed until 04/03/2002
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 10/07/2001 and displayed until 20/08/2001
Reasons for adding or updating:
  • Transferred from eMC version 1
Updated on 06/09/1999 and displayed until 10/07/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
  estramustine sodium phosphate